Gsk (GSK) Debt Ratio (2016 - 2026)

Gsk has reported Debt Ratio over the past 18 years, most recently at 0.31 for Q1 2026.

For Q1 2026, Debt Ratio rose 16.58% year-over-year to 0.31; the TTM value through Mar 2026 reached 0.31, up 16.58%, while the annual FY2025 figure was 0.33, 215.34% down from the prior year.
Debt Ratio for Q1 2026 was 0.31 at Gsk, up from 0.33 in the prior quarter.
Over five years, Debt Ratio peaked at 0.31 in Q4 2023 and troughed at 0.43 in Q3 2022.
A 5-year average of 0.23 and a median of 0.33 in 2025 define the central range for Debt Ratio.
Biggest five-year swings in Debt Ratio: rose 17.6% in 2022 and later crashed 215.34% in 2025.
Year by year, Debt Ratio stood at 0.3 in 2022, then rose by 0.16% to 0.31 in 2023, then dropped by 6.59% to 0.29 in 2024, then tumbled by 215.34% to 0.33 in 2025, then increased by 6.67% to 0.31 in 2026.
Business Quant data shows Debt Ratio for GSK at 0.31 in Q1 2026, 0.33 in Q4 2025, and 0.33 in Q3 2025.

Peer Comparison